Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mikhail Ivanovich Papisov, Ph.D.

Co-Author

This page shows the publications co-authored by Mikhail Papisov and Ralph Weissleder.
Connection Strength

0.502
  1. Drug delivery to lymphatic tissue. Crit Rev Ther Drug Carrier Syst. 1996; 13(1-2):57-84.
    View in: PubMed
    Score: 0.166
  2. Drug targeting in magnetic resonance imaging. Magn Reson Q. 1992 Mar; 8(1):55-63.
    View in: PubMed
    Score: 0.127
  3. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies. Radiology. 1996 Feb; 198(2):365-70.
    View in: PubMed
    Score: 0.042
  4. [Presentation and quantification of acute myocardial infarct using antibody-bound MR contrast medium]. Z Kardiol. 1995 Apr; 84(4):311-5.
    View in: PubMed
    Score: 0.039
  5. Determinants of in vivo MR imaging of slow axonal transport. Radiology. 1994 Nov; 193(2):485-91.
    View in: PubMed
    Score: 0.038
  6. MR lymphography: study of a high-efficiency lymphotrophic agent. Radiology. 1994 Apr; 191(1):225-30.
    View in: PubMed
    Score: 0.037
  7. MION-ASF: biokinetics of an MR receptor agent. Magn Reson Imaging. 1993; 11(3):411-7.
    View in: PubMed
    Score: 0.034
  8. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM. Magn Reson Med. 1995 Jan; 33(1):88-92.
    View in: PubMed
    Score: 0.010
  9. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med. 1993 May; 29(5):599-604.
    View in: PubMed
    Score: 0.009
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.